AAAAAA
Results: 26-50/62
Authors:
PRESKORN SH
HARVEY AT
Citation: Sh. Preskorn et At. Harvey, BIOCHEMICAL AND CLINICAL DOSE-RESPONSE CURVES WITH SERTRALINE, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 85-85
Authors:
PRESKORN SH
Citation: Sh. Preskorn, EFFECTS OF ANTIDEPRESSANTS ON THE CYTOCHROME-P450 SYSTEM, The American journal of psychiatry, 153(12), 1996, pp. 1655-1656
Authors:
BURKE MJ
HARVEY AT
PRESKORN SH
Citation: Mj. Burke et al., PHARMACOKINETICS OF THE NEWER ANTIDEPRESSANTS, The American journal of medicine, 100(1), 1996, pp. 119-120
Authors:
PRESKORN SH
Citation: Sh. Preskorn, SHOULD RATIONAL DRUG DEVELOPMENT IN PSYCHIATRY TARGET MORE THAN ONE MECHANISM OF ACTION IN A SINGLE-MOLECULE, International review of psychiatry, 7(1), 1995, pp. 17-28
Authors:
PRESKORN SH
LANE RM
Citation: Sh. Preskorn et Rm. Lane, SERTRALINE 50 MG DAILY - THE OPTIMAL DOSE IN THE TREATMENT OF DEPRESSION, International clinical psychopharmacology, 10(3), 1995, pp. 129-141
Authors:
PRESKORN SH
Citation: Sh. Preskorn, COMPARISON OF THE TOLERABILITY OF BUPROPION, FLUOXETINE, IMIPRAMINE, NEFAZODONE, PAROXETINE, SERTRALINE, AND VENLAFAXINE, The Journal of clinical psychiatry, 56, 1995, pp. 12-21
Authors:
PRESKORN SH
Citation: Sh. Preskorn, BEYOND DSM-IV - WHAT IS THE CART AND WHAT IS THE HORSE, Psychiatric annals, 25(1), 1995, pp. 53-62
Authors:
PRESKORN SH
BAKER BS
Citation: Sh. Preskorn et Bs. Baker, OUTPATIENT MANAGEMENT OF THE DEPRESSED PATIENT, Disease-a-month, 41(2), 1995, pp. 1
Authors:
HARVEY AT
PRESKORN SH
Citation: At. Harvey et Sh. Preskorn, INTERACTIONS OF SEROTONIN REUPTAKE INHIBITORS WITH TRICYCLIC ANTIDEPRESSANTS, Archives of general psychiatry, 52(9), 1995, pp. 783-784
Authors:
LACEY RL
PRESKORN SH
JERKOVICH GS
Citation: Rl. Lacey et al., IS RISPERIDONE A SUBSTITUTE FOR CLOZAPINE FOR PATIENTS WHO DO NOT RESPOND TO NEUROLEPTICS, The American journal of psychiatry, 152(9), 1995, pp. 1401-1401
Authors:
PRESKORN SH
Citation: Sh. Preskorn, THERAPEUTIC DRUG-MONITORING WITH TRICYCLIC ANTIDEPRESSANTS - A RESPONSE, Journal of clinical psychopharmacology, 14(4), 1994, pp. 277-278
Authors:
PRESKORN SH
ALDERMAN J
CHUNG M
HARRISON W
MESSIG M
HARRIS S
Citation: Sh. Preskorn et al., PHARMACOKINETICS OF DESIPRAMINE COADMINISTERED WITH SERTRALINE OR FLUOXETINE, Journal of clinical psychopharmacology, 14(2), 1994, pp. 90-98
Authors:
WELLER RA
KAPADIA P
WELLER EB
FRISTAD M
LAZAROFF LB
PRESKORN SH
Citation: Ra. Weller et al., PSYCHOPATHOLOGY IN FAMILIES OF CHILDREN WITH MAJOR DEPRESSIVE-DISORDERS, Journal of affective disorders, 31(4), 1994, pp. 247-252
Authors:
PRESKORN SH
Citation: Sh. Preskorn, UPDATE ON ANTIDEPRESSANT THERAPY - INTRODUCTION, The Journal of clinical psychiatry, 55, 1994, pp. 3-5
Authors:
PRESKORN SH
Citation: Sh. Preskorn, ANTIDEPRESSANT DRUG SELECTION - CRITERIA AND OPTIONS, The Journal of clinical psychiatry, 55, 1994, pp. 6-22
Authors:
RICHELSON E
PRESKORN SH
FEIGHNER JP
CUNNINGHAM LA
ROOSE SP
KELLER MB
Citation: E. Richelson et al., ANTIDEPRESSANT DRUG SELECTION - CRITERIA AND OPTIONS - DISCUSSION, The Journal of clinical psychiatry, 55, 1994, pp. 23-24
Authors:
FEIGHNER JP
KELLER MB
PRESKORN SH
ROOSE SP
DREVETS WC
Citation: Jp. Feighner et al., THE NATURAL-HISTORY AND HETEROGENEITY OF DEPRESSIVE-DISORDERS - IMPLICATIONS FOR RATIONAL ANTIDEPRESSANT THERAPY - DISCUSSION, The Journal of clinical psychiatry, 55, 1994, pp. 32-33
Authors:
PRESKORN SH
RICHELSON E
ROOSE SP
FEIGHNER JP
CUNNINGHAM LA
DREVETS WC
Citation: Sh. Preskorn et al., THE PHARMACOLOGY OF ANTIDEPRESSANTS AT THE SYNAPSE - FOCUS ON NEWER COMPOUNDS - DISCUSSION, The Journal of clinical psychiatry, 55, 1994, pp. 40-40
Authors:
BURKE MJ
SILKEY B
PRESKORN SH
Citation: Mj. Burke et al., PHARMACOECONOMIC CONSIDERATIONS WHEN EVALUATING TREATMENT OPTIONS FORMAJOR DEPRESSIVE DISORDER, The Journal of clinical psychiatry, 55, 1994, pp. 42-52
Authors:
FEIGHNER JP
BURKE MJ
PRESKORN SH
KELLER MB
DREVETS WC
Citation: Jp. Feighner et al., PHARMACOECONOMIC CONSIDERATIONS WHEN EVALUATING TREATMENT OPTIONS FORMAJOR DEPRESSION - DISCUSSION, The Journal of clinical psychiatry, 55, 1994, pp. 53-54
Authors:
ROOSE SP
NIERENBERG AA
PRESKORN SH
FEIGHNER JP
DREVETS WC
Citation: Sp. Roose et al., THE TREATMENT OF SEVERE DEPRESSION - IS THERE AN EFFICACY GAP BETWEENSSRI AND TCA ANTIDEPRESSANT GENERATIONS - DISCUSSION, The Journal of clinical psychiatry, 55, 1994, pp. 60-61
Authors:
CUNNINGHAM LA
FEIGHNER JP
ROOSE SP
RICHELSON E
PRESKORN SH
DREVETS WC
Citation: La. Cunningham et al., THE ROLE OF VENLAFAXINE IN RATIONAL ANTIDEPRESSANT THERAPY - DISCUSSION, The Journal of clinical psychiatry, 55, 1994, pp. 69-70
Authors:
RICHELSON E
DREVETS WC
PRESKORN SH
Citation: E. Richelson et al., GERIATRIC DEPRESSION - BRAIN IMAGING CORRELATES AND PHARMACOLOGICAL CONSIDERATIONS - DISCUSSION, The Journal of clinical psychiatry, 55, 1994, pp. 82-82
Authors:
FEIGHNER JP
ROOSE SP
PRESKORN SH
Citation: Jp. Feighner et al., ANTIDEPRESSANT CHOICE IN THE PATIENT WITH CARDIAC DISEASE - LESSONS FROM THE CARDIAC-ARRHYTHMIA SUPPRESSION TRIAL (CAST) STUDIES - DISCUSSION, The Journal of clinical psychiatry, 55, 1994, pp. 88-88
Authors:
PRESKORN SH
CUNNINGHAM LA
ROOSE SP
Citation: Sh. Preskorn et al., DEPRESSION IN THE MEDICALLY ILL - CHOOSING AN ANTIDEPRESSANT - DISCUSSION, The Journal of clinical psychiatry, 55, 1994, pp. 97-97